October 21, 2015 — Stage III non-small cell lung cancer (NSCLC) patients receiving intensity-modulated radiation therapy (IMRT) have 44 percent fewer cases of severe pneumonitis and improved likelihood of completing consolidative chemotherapy after radiation, compared to patients who receive three-dimensional conformal radiation therapy (3-D CRT). These findings were derived from research presented at the American Society for Radiation Oncology’s (ASTRO’s) 57th annual meeting.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now